Callan Family Office’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
SG
Callan Family Office's PTEN Position: Q2 2026 in Review
Callan Family Office increased its Patterson-UTI (PTEN) stake by 0.4% in Q2 2026, buying an estimated $1.82K and bringing the position to 40,908 shares worth $376K. The position accounts for 0.01% of the portfolio, ranked #920.
Callan Family Office first reported a position in PTEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $441K in Q1 2026. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.
- Callan Family Office held 40,908 shares of Patterson-UTI worth $376K as of Q2 2026.
- Callan Family Office bought 163 Patterson-UTI shares in Q2 2026, an estimated $1.82K.
- Patterson-UTI made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #920 holding.
- Callan Family Office first reported a position in Patterson-UTI in Q2 2025 and has held it in 4 quarters since.
- Callan Family Office's Patterson-UTI position peaked at $441K in Q1 2026.
- 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.